Skip to main content
. 2016 Dec 12;39(1):71–80. doi: 10.3892/ijmm.2016.2826

Figure 12.

Figure 12

Inhibition of c-Jun N-terminal kinase (JNK) expression enhances alkaline phosphatase (ALP) activity, and increases collagen type I (Col I), osteocalcin (OCN) and osteopontin (OPN) gene expression in bone marrow-derived mesenchymal stem cells (BMSCs) following the overexpression of miR-214. Inhibition of JNK expression increased (A) ALP activity, and (B) Col I, (C) OCN and (D) OPN gene expression in BMSCs. Control, control group; miR-124, miR-124 infection group; JNK inhibitor, JNK inhibitor (SP600125) group. *p<0.01 compared with the control group; #compared with the miR-124 infection group.